Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

35.960
-2.040-5.37%
Volume:10.83M
Turnover:404.67M
Market Cap:8.88B
PE:279.31
High:39.680
Open:39.200
Low:35.740
Close:38.000
52wk High:52.200
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:2.03
T/O Rate:8.16%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.129
ROE:0.82%
ROA:-0.80%
PB:1.52
PE(LYR):279.31
PS:6.14

Loading ...

AH Share Premium Report: August 31 Market Close

Stock News
·
Aug 31

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Reuters
·
Aug 31

Movement Alert|CANSINOBIO Falls 5.48% in Regular Trading, Profit-Taking Continues After Multiple Catalysts Drove Sharp Rally

Market Focus
·
Aug 31

AH Premium Rankings for August 28: NE Electric Leads, CATL Records Negative Premium

Stock News
·
Aug 28

Movement Alert|CANSINOBIO Falls 5.4% in Regular Trading, Profit-Taking Continues After Multi-Catalyst Rally and H1 Results Release

Market Focus
·
Aug 28

CanSinoBIO Posts 46% Revenue Growth and Near-Break-Even First-Half Result, Boosted by Meningococcal and Pneumococcal Vaccines

Bulletin Express
·
Aug 27

AH Premium Rankings for August 27: A Market Overview

Stock News
·
Aug 27

Movement Alert|CANSINOBIO Declines 5.04% in Regular Trading, Pullback Continues After mRNA Cooperation-Fueled Surge

Market Focus
·
Aug 27

CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines

MT Newswires Live
·
Aug 26

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Stock News
·
Aug 26

HK Biotech Shares Surge as CansinoBio Jumps Over 18%

Deep News
·
Aug 26

Movement Alert|CANSINOBIO Rises 14.34% in Regular Trading, Strategic mRNA Tumor Vaccine Partnership with Depushi Bio Announced

Market Focus
·
Aug 26

Movement Alert|CANSINOBIO Rises 6.15% in Regular Trading, Rebounding After Multi-Day Pullback as Broker Flags Severe Undervaluation in mRNA Sector

Market Focus
·
Aug 25

AH Share Premium Rankings: Market Close Update for August 24

Stock News
·
Aug 24

Movement Alert|CANSINOBIO Declines 5.16% in Regular Trading, Profit-Taking Continues After mRNA-Driven Surge

Market Focus
·
Aug 24

AH Share Premium Tracker | August 21 Market Close

Stock News
·
Aug 21

Movement Alert|CANSINOBIO Intraday Decline 7.99%, Pullback Following Previous Sessions Massive mRNA Vaccine-Driven Rally

Market Focus
·
Aug 21

CanSino Biologics' Application for Tetanus Vaccine Approved in China

MT Newswires Live
·
Aug 20

AH Share Premium Ranking Update: August 20 Market Close

Stock News
·
Aug 20

Chinese Vaccine Makers Jump on News of Key Success in Cancer Treatment, CanSino Leads

Reuters
·
Aug 20